Transcription of Annex 3 - WHO
{{id}} {{{paragraph}}}
119 Annex 3 Good manufacturing practices: guidelines on validation Background The need for revision of the published World Health Organization (WHO) Supplementary guidelines on good manufacturing practices: validation (1) was identified by the Prequalification of Medicines Programme and a first draft document was circulated for comment in early 2013. The focus, at that time, was revision of the appendix on Non-sterile process validation (Appendix 7) (2), which had been revised and was adopted by the ECSPP at its Forty-ninth meeting in October 2014 (3). The overarching text presented in this Annex constitutes the general principles of the new guidance on validation .
Cleaning validation (as published in TRS and TRS 937, Annex 4, 2006 and as cross-reference to TRS 970, Annex 2, 2012 (5) Appendix 4. Analytical procedure validation (adopted, subject to ... when changes are made, depending on the outcome of risk assessment; where necessary or indicated, based on the outcome ofperiodic
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}